Calnic Plus

Quick links to important sections

Calnic Plus

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Calnic Plus

Quick Facts

Component Typical Strength (per dose)
Calcium Carbonate 400 mg
Cholecalciferol (Vitamin D3) 200 IU

Calnic Plus is a dietary supplement combining Calcium and Vitamin D3 (cholecalciferol). This combination is primarily used to address or prevent low levels of these nutrients in the body, which can occur when dietary intake is insufficient.

Calcium is an essential mineral that plays a vital role in numerous bodily functions, including maintaining the strength and density of bones and teeth. It is also necessary for the proper function of nerves, muscles, and the heart.

Vitamin D3 is crucial because it helps the body absorb calcium from the intestines, making it highly effective when taken together with calcium supplements. Adequate levels of both calcium and Vitamin D are important for bone formation and maintenance, which can help prevent conditions like osteoporosis and rickets.

Healthcare providers may recommend calcium and Vitamin D3 supplementation for individuals who are at risk of deficiency, such as older adults, postmenopausal women, or those with certain medical conditions that affect nutrient absorption. It is important to consult a healthcare professional to determine the appropriate dosage for individual needs.

What side effects are possible with Calnic Plus?

The official safety documentation for the combination of calcium carbonate and cholecalciferol (Vitamin D3) primarily centers on the risk of mineral imbalance and effects on the gastrointestinal tract.

Adverse Reactions by Frequency and System

Side effects are generally categorized by the organ system they affect. Uncommon adverse reactions listed in regulatory documents are Hypercalcaemia (excess calcium in the blood) and Hypercalciuria (excess calcium in the urine). These reflect disturbances in the body's metabolism and nutrition [1.1].

Gastrointestinal disturbances are frequently cited, including constipation, flatulence, nausea, abdominal pain, and diarrhoea, which are classified as rare [1.1]. Rare dermatological reactions, such as pruritus (itching), rash, and urticaria (hives), have also been documented.

Serious Safety Considerations

The most serious safety concerns, though rare, relate to high calcium levels. These include the development of Milk-alkali syndrome—a triad of hypercalcaemia, metabolic alkalosis, and renal insufficiency—which is generally associated with chronic high-dose intake [2.1]. Severe hypercalcaemia may lead to irreversible renal damage and soft tissue calcification, including nephrocalcinosis [1.1]. Hypersensitivity reactions are also documented [1.3].

Population-Specific Constraints

The regulatory labels specify certain safety limitations. The product is contraindicated in patients with pre-existing hypercalcaemia, severe hypercalciuria, or severe renal impairment [1.5]. Caution is required for patients with sarcoidosis or a history of renal calculi (kidney stones) [1.5]. Official documents advise avoiding Vitamin D overdose during pregnancy and lactation due to associated risks [1.5].

Safety Monitoring

For individuals undergoing long-term treatment, the regulatory safety profile mandates routine monitoring of serum calcium levels and renal function [1.6].

This official safety structure highlights the necessity of maintaining mineral homeostasis and defines clear restrictions for specific conditions, structuring the understanding of the medicine’s risk profile.

Overdose and Emergency Response

Overdose and when to seek help

The official overdose profile for Calnic Plus (Calcium Carbonate and Cholecalciferol) is defined by the toxic effects of excessive amounts, primarily resulting in Hypercalcaemia and Hypervitaminosis D, as documented in government regulatory sources.

Overdose manifestations typically present with non-specific systemic symptoms including anorexia, nausea, vomiting, and constipation, alongside increased thirst (polydipsia) and frequent urination (polyuria). Neuromuscular and mental disturbances such as muscle weakness, fatigue, and lethargy are also documented clinical signs.


When to Seek Immediate Medical Attention

The regulatory guidance mandates that immediate medical help must be sought if an overdose is suspected. Severe manifestations necessitate urgent intervention due to the risk of life-threatening outcomes, including cardiac arrhythmias, coma, and irreversible renal damage (nephrocalcinosis).


Management and Monitoring

The official management strategy is defined as symptomatic and supportive treatment, as no specific antidote is known for this toxicity. Treatment requires the immediate discontinuation of the product. Monitoring requirements include observation of serum electrolytes, renal function, and ECG monitoring.

Population-specific warnings emphasize that patients with impaired renal function are more susceptible to toxic effects, and overdose must be avoided during pregnancy due to the risk of adverse effects on the developing foetus.

Therapeutic Uses of Calnic Plus

What Calnic Plus Treats: Main Uses and Benefits

Calnic Plus (Calcium Carbonate and Cholecalciferol) is commonly used to help with conditions and symptoms related to systemic imbalance created by nutritional deficits of Calcium and Vitamin D3. The product provides support that helps ease the overall symptom burden and contributes to maintaining a sense of stability when symptoms are more noticeable. It is commonly used along with calcium to address the underlying deficits relevant to bone diseases.


Key Therapeutic Domains

The supplement is applied across therapeutic domains involving deficiencies that compromise skeletal structure and neuromuscular function. It is relevant for easing symptoms associated with bone fragility, such as in cases of Osteoporosis and Osteomalacia, and in supportive contexts for developmental conditions like Rickets. Furthermore, it is used to address groups of symptoms related to low calcium levels, including painful muscle cramps and spasms.

Quick Fact: Relief for Muscular Distress Calnic Plus is relevant for easing symptoms that interfere with daily comfort, such as involuntary muscle contractions linked to mineral imbalance.

This supportive function is also key in high-demand phases. The product supports general well-being during symptomatic periods in groups like older adults and postmenopausal women, and during life stages such as pregnancy and breastfeeding.

Regulatory References

  1. NIH MedlinePlus overview on Cholecalciferol (Vitamin D3)

Eligibility and Restrictions for Use

Who Can and Cannot Use Calnic Plus?

This section describes the population eligibility rules for Calnic Plus (Calcium Carbonate and Cholecalciferol) based strictly on official regulatory labeling. Eligibility is primarily defined by the risks associated with existing mineral imbalances and compromised organ function.


Contraindicated Populations

Calnic Plus is contraindicated and must not be used by patients with:

  • Hypercalcaemia (abnormally high blood calcium levels).
  • Hypercalciuria (excessive calcium in the urine).
  • Hypervitaminosis D (Vitamin D overdose).
  • Severe Renal Impairment or Nephrocalcinosis (calcium deposits in the kidneys).
  • Known Nephrolithiasis (kidney stones).
  • Hypersensitivity to the active substances or excipients.

Population and Condition Restrictions

Category Official Eligibility Status
Eligible Population Primarily Adults and the Elderly for documented deficiencies.
Pediatric Use Generally not recommended or contraindicated for specific high-dose formulations.
Renal Impairment Severe impairment is contraindicated. Mild to moderate impairment requires caution and monitoring.
Pregnancy/Lactation Permitted only if a documented deficiency is strictly indicated, with close monitoring of total daily intake.

Eligibility is limited by the risk of mineral toxicity and is not intended for the general population but for the correction of medically confirmed deficiency states.

What should I know about interactions with other medicines?

Calnic Plus Interactions with other medicines and products

Interaction scope

Category Official Regulatory Documentation Statement
Medicinal product categories with documented interactions Antibiotics (tetracyclines, quinolones), Cardiac Glycosides, Thiazide Diuretics, Anticonvulsants, Bisphosphonates, Thyroid Hormones, Bile Acid Sequestrants, Corticosteroids.
Specific interacting medicines (if explicitly listed) Phenytoin, Phenobarbital, Digoxin, Cholestyramine, Orlistat, Mineral Oil, Levothyroxine.
Mechanistic basis of interactions (only if stated in label) Physico-chemical chelation (calcium binding), Enzyme induction (accelerated Vitamin D3 metabolism), and Additive pharmacodynamic effects (increased hypercalcemia risk).
Timing-based interaction rules (if applicable) Mandatory separation of administration is required for co-administration with Tetracycline and Quinolone antibiotics, Bisphosphonates, and Levothyroxine to prevent reduced systemic exposure of the co-administered drug.
Population-specific interaction notes (if applicable) The official risk of hypercalcemia due to interaction or supplementation is heightened in patients with renal impairment.
Interaction-related restrictions Co-administration with other pharmacologic doses of Vitamin D or its Analogs is advised to be avoided due to the additive risk of hypercalcemia and toxicity. Co-administration with Cardiac Glycosides or Thiazide Diuretics requires regulatory caution.

Interaction classifications (high-level)

Classification Official Regulatory Documentation Statement
Interaction severity classification (as defined in official documents) Interactions classified as Contraindicated (e.g., Vitamin D Analogs), Requiring Administration Timing Rules (e.g., Antibiotics, Levothyroxine), and Requiring Caution/Monitoring (e.g., Digoxin, Thiazide Diuretics).
Regulatory basis (EMA / FDA / etc.) Based on standardized prescribing information documented by government health authorities.
Interaction-context constraints (as defined in official documents) Officially documented interaction with Oxalic Acid and Phytic Acid found in foods (spinach, rhubarb, whole grains) due to formation of insoluble calcium salts, reducing absorption.

Resulting interaction structure

Official interaction statements:

  • Co-administration with Tetracycline and Quinolone antibiotics must be separated by several hours to mitigate reduced antibiotic exposure resulting from physico-chemical chelation by the calcium component.
  • Thiazide Diuretics reduce urinary calcium excretion, creating an additive pharmacodynamic effect that officially increases the risk of hypercalcemia when co-administered.
  • The use of Cardiac Glycosides necessitates caution, as calcium can potentiate their effects, increasing the official risk of arrhythmias in cases of hypercalcemia.
  • Anticonvulsants like Phenytoin and Phenobarbital are documented as inducing enzymes that accelerate the degradation of Cholecalciferol (Vitamin D3) to inactive metabolites, thereby reducing its systemic exposure.
  • Substances that interfere with fat absorption, such as Cholestyramine, Mineral Oil, and Orlistat, are officially noted to reduce the bioavailability of fat-soluble Cholecalciferol.

Connection to the overall interaction profile (2–4 sentences): Regulatory documents define the product’s interaction structure primarily around mandatory separation rules to prevent gastrointestinal binding of co-administered agents by calcium, and specific cautions against combinations that increase the systemic risk of hypercalcemia. The profile also notes pharmacokinetic interactions where certain medicinal products, such as anticonvulsants, reduce the therapeutic exposure of the cholecalciferol component through enzyme-mediated metabolism. The overall framework is strictly procedural and risk-based, identifying agents that alter the exposure or pharmacodynamic outcome of either component.

Mechanism of Action

The mechanism of Calnic Plus involves a dual-component process focused on mineral availability and hormonal regulation. The formulation introduces elemental calcium which is absorbed systemically via intestinal transport mechanisms. Concurrently, Vitamin D3 (cholecalciferol) acts as a precursor that is metabolized to its active form, which functions as a nuclear receptor agonist. This activated hormone binds to the Vitamin D Receptor (VDR) on intestinal epithelial cells, upregulating the transcription of proteins necessary for calcium absorption, thereby facilitating increased influx across the epithelium.

Systemically, the absorbed calcium is utilized as a substrate for bone matrix mineralization. Calcium and its regulatory pathways influence osteoblast and osteoclast activity, thereby modulating bone remodeling kinetics. This component interaction contributes to the dynamic regulation of calcium homeostasis across the skeletal and plasma compartments, maintaining physiological balance without reference to specific clinical outcomes or patient-relevant improvements.

Dosage and Administration Information

The official use of Calnic Plus (Calcium Carbonate 400 mg / Cholecalciferol 200 IU) is defined by several key administration principles. The administration method is strictly oral for this formulation, which must be taken with food as per the official labeled instructions to enhance the absorption of the calcium component. A full glass of water is required to facilitate swallowing and proper breakdown of the tablet.

The dosing schedule is defined as a divided-dose pattern, typically administered up to three times daily, rather than a single large dose. This frequency is established to optimize the amount of elemental calcium the body can effectively absorb throughout the day. Instructions explicitly state that users must not exceed the maximum recommended daily dose specified on the product labeling.

Furthermore, usage guidelines emphasize that this supplement is intended for long-term daily maintenance to support skeletal health. It is not administered in cycles or short courses. The labeling for the product contains specific instructions regarding use in pediatric patients, where dosage adjustments or use limits often apply, necessitating guidance from a health professional.

Recent Clinical Evidence

Calnic Plus: Recent Clinical Evidence

Research exploring the combination in the context of bone health has primarily focused on groups considered at higher risk for bone fragility, such as older adults and postmenopausal women. Studies explored the supplement using large, controlled trials and comprehensive analyses, examining outcomes like the incidence of fractures and changes in Bone Mineral Density (BMD). Data show that findings were mixed across studies. Differences in fracture risk were noted between the supplement group and the placebo group in institutionalized adults, but these findings were not universally consistent across all community-dwelling populations studied.


Evidence also exists for the combination where clear nutritional deficiencies were identified, such as in cases of nutritional rickets in children and osteomalacia in adults. Research describes trials that monitored changes in fundamental biological markers and bone structure. These studies showed that biomarkers often evolved toward studied ranges in individuals with low baseline levels due to severe deficiency. However, follow-up durations were limited in much of this research.


Research examined the combination in special groups including pregnant and lactating women. Studies monitored various outcomes, including maternal status and offspring bone mineral density. Findings in these groups were mixed and inconclusive regarding the impact on bone mineral density in both the mother and the newborn. Long-term effects for the child's bone health are not fully established.


Areas Where Research Remains Inconsistent or Limited

The overall consistency of findings remains a key area of discussion, particularly regarding fracture risk reduction in healthy adults. Long-term effects on the durability of skeletal structure are not fully established, and the research has not provided extensive clarification on subgroup findings regarding combined versus single-nutrient supplementation.

Frequently Asked Questions (FAQ)

Common questions about Calnic Plus (FAQ)


Q: What is the main difference between Calnic Plus and a regular calcium supplement?

Calnic Plus is a combination supplement containing both Calcium Carbonate and Cholecalciferol (Vitamin D3). The key difference is the addition of Vitamin D3, which is included to help the body absorb the elemental calcium from the intestines. Regulatory documents describe regular calcium supplements as containing only the calcium component.


Q: Why is Calnic Plus often prescribed together with other drugs?

Official information indicates that the combination is frequently used as a supplement adjunct to specific treatments, such as certain osteoporosis medications. The purpose is to help prevent or treat low levels of Vitamin D and calcium, especially when patients are at risk of deficiency.


Q: Why do some people experience mild headaches after starting Calnic Plus?

Headache is not typically listed among the common or rare side effects documented in the official safety information for this combination. However, headache is reported as a possible symptom of an overdose or hypercalcaemia (excess calcium in the blood), which regulatory documents classify as an uncommon adverse reaction.


Q: Can Calnic Plus affect the results of blood tests?

Yes, regulatory documents require the routine monitoring of serum calcium levels and renal function for individuals undergoing long-term treatment with this combination. This monitoring is necessary because the supplement is understood to influence the body's mineral balance, which can affect blood chemistry results.


Q: Is it normal to feel tired when starting a course of Calnic Plus?

Unusual tiredness or weakness is not listed as a common adverse reaction in the official safety profile. It is noted, however, that symptoms associated with hypercalcaemia (excess calcium in the blood) or overdose can sometimes include unusual weakness or drowsiness.


Q: Does Calnic Plus cause dry mouth?

Dry mouth has been reported as a possible side effect of the Calcium Carbonate component of this supplement. Should any side effects occur, official information recommends consulting a healthcare provider.


Q: Does Calnic Plus contain dairy or gluten ingredients?

The specific inactive ingredients, or excipients, can vary by manufacturer. While some official product information lists components like sucrose or soya-bean oil derivatives, product information indicates that specific ingredients should be reviewed on the product label to confirm the absence of dairy, gluten, or other specific components.


Q: Is it true that Calnic Plus can affect thyroid function?

The supplement itself is not officially noted to affect thyroid function. However, the calcium component can reduce the absorption of co-administered thyroid hormones, such as levothyroxine, which requires specific separation of administration times as described in the interaction documentation.


Q: Is Calnic Plus available without a prescription?

In many regulatory markets, the combination of Calcium Carbonate and Cholecalciferol in this strength is typically classified as a Dietary Supplement. As such, it is generally available Over-the-Counter (OTC) without the need for a prescription.


Q: What is the actual purpose of the 'Plus' component in Calnic Plus?

The 'Plus' refers to the addition of Cholecalciferol (Vitamin D3) to the calcium component. Regulatory and product information states that Vitamin D3 is included because it is essential to help the body absorb the calcium from the intestinal tract and facilitate its use in supporting bone health.


Q: Are there any long-term side effects associated with taking Calnic Plus?

Long-term use requires regulatory caution, and official safety profiles mandate the routine monitoring of serum calcium levels and renal function. Risks associated with chronic high-dose intake include the potential for rare but serious conditions like Milk-alkali syndrome and severe hypercalcaemia (excess calcium in the blood).


Q: Is Calnic Plus appropriate for use in children?

Pediatric use, especially in children under a certain age (e.g., under 4 years old), requires consultation with a health professional for appropriate indication and dosing. Some high-dose formulations are generally not recommended for use in children.


Q: What is the age limit for people who can use Calnic Plus?

Official labeling for many formulations states that for children under a specific age, such as under 4 years, a health professional must be consulted before use. Eligibility is primarily targeted toward adults, with specific usage guidelines applying to the pediatric population.


Q: Is there a generic version of Calnic Plus available?

Yes, the core combination of Calcium Carbonate and Cholecalciferol is widely available as a generic equivalent from multiple manufacturers. The generic products are generally considered to contain the same active ingredients.


Q: Do food ingredients affect how Calnic Plus is absorbed?

Yes, official product instructions state that the supplement is typically taken with food to maximize absorption. Conversely, foods high in oxalic acid (e.g., spinach, rhubarb) or phytic acid (e.g., whole grains) are documented to potentially reduce the amount of calcium the body absorbs.


Q: Is Calnic Plus used for any conditions other than bone or calcium issues?

Official information indicates the primary use is to address or prevent low levels of calcium and Vitamin D. In addition, the Calcium Carbonate component in the supplement is sometimes used as an antacid to relieve symptoms like heartburn and acid indigestion.


Q: Are there different formulas of Calnic Plus sold internationally?

Yes, the combination of Calcium Carbonate and Cholecalciferol is sold globally, and official information indicates there are often variations in the strengths (milligrams/IU) and dosage forms (such as chewable tablets or capsules) depending on the region and manufacturer.


Q: Can Calnic Plus be taken on an empty stomach?

The official administration instructions for the calcium carbonate formulation state that it is typically taken with food. This instruction is given to maximize the absorption of the calcium component, particularly for people with low stomach acid.


Q: Does Calnic Plus have a sedative effect?

Sedation or sleepiness is not listed as an official adverse reaction in the safety documents. However, symptoms associated with hypercalcaemia or overdose can sometimes include drowsiness.


Q: Does Calnic Plus contain any ingredients that cause sleeplessness?

Sleeplessness (or insomnia) is not listed as an official adverse reaction in the regulatory safety profile of the supplement.


Q: Is the 'Plus' ingredient in Calnic Plus common in other treatments?

Yes, the 'Plus' ingredient, Cholecalciferol (Vitamin D3), is widely used. It is available as a single-ingredient supplement and is also frequently combined with other medications, particularly those used for managing bone health conditions.


Q: How long does Calnic Plus stay in your system after stopping treatment?

Official pharmacokinetic data indicates that the active metabolite of Cholecalciferol (Vitamin D3) has a prolonged presence in the body. The primary active form of the Vitamin D component has a half-life of approximately 15 hours, while another related metabolite can have a half-life of about 15 days.

How should Calnic Plus be stored and disposed of?

How to Store and Dispose of Calnic Plus?

The official storage and disposal requirements for Calnic Plus (Calcium Carbonate and Cholecalciferol) are strictly defined to ensure product quality and public safety.


Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature, between 20 C and 25 C (68 F and 77 F).
Prohibited Do not freeze the product under any circumstances.
Packaging Keep the container tightly closed and store in its original packaging.
Safety The medicine must be kept out of the sight and reach of children.

Disposal Instructions

Any unused or expired product must be disposed of according to local regulations and community guidelines. Do not dispose of Calnic Plus by flushing it down a toilet or pouring it into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Calnic Plus found in:

A-Z Index: